Topics

High fever after sublingual administration of misoprostol for treatment of postpartum hemorrhage: A hospital-based, prospective observational study in Argentina.

08:00 EDT 10th March 2020 | BioPortfolio

Summary of "High fever after sublingual administration of misoprostol for treatment of postpartum hemorrhage: A hospital-based, prospective observational study in Argentina."

To characterize the occurrence of fever (≥38.0°C) after treatment for postpartum hemorrhage (PPH) with sublingual misoprostol 800 mcg in Latin America, where elevated rates of misoprostol's thermoregulatory effects and recipients' increased susceptibility to high fever have been documented.

Affiliation

Journal Details

This article was published in the following journal.

Name: Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Pages:

Links

DeepDyve research library

PubMed Articles [33607 Associated PubMed Articles listed on BioPortfolio]

Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach.

To characterize the use of the drug misoprostol for treatment of postpartum hemorrhage in pregnant women.

Misoprostol administration prior to intrauterine contraceptive device insertion: a systematic review and meta-analysis of randomised controlled trials.

Misoprostol has been used before intrauterine contraceptive device (IUCD) insertion to prime the cervical os. As the literature about this topic is controversial, we aimed to evaluate IUCD insertion f...

A factorial-design randomized controlled trial comparing misoprostol alone to Dilapan with misoprostol and comparing buccal to vaginal misoprostol for same-day cervical preparation prior to Dilation & Evacuation at 14weeks 0days to 19weeks 6days gestation.

To compare procedure times following same-day cervical preparation using misoprostol 400 mcg alone or misoprostol 400 mcg plus hygroscopic dilators for dilation and evacuation (D&E) before 20weeks ges...

Brexanolone Is the First Drug Specifically for Postpartum Depression.

Postpartum depression is a mood disorder that affects up to 20% of women in the first year after childbirth. Symptoms can range from mild depression and anxiety to severe mood alterations and psychos...

Coronary artery vasospasm after misoprostol treatment for incomplete abortion: A case report.

Misoprostol is widely used for the medical management of incomplete abortion. Few serious adverse events have been reported, so it is considered a safe drug. We present a case of 40-year-old women in ...

Clinical Trials [11104 Associated Clinical Trials listed on BioPortfolio]

Fever After Misoprostol Administration for the Treatment of Primary Postpartum Hemorrhage

This study will evaluate side effects after sublingual misoprostol (600 mcg) as a first-line treatment for primary postpartum hemorrhage (PPH) due to suspected uterine atony.

Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation

This open-label, randomized study is being conducted to determine whether a dose of 400 mcg of sublingual misoprostol (i.e., under the tongue) taken 24 hours following administration of mi...

Misoprostol in the Prevention of Postpartum Haemorrhage

Postpartum haemorrhage is a major contributor to maternal mortality in the developing world. The incidence is between 5 and 12% in Jamaica and varies depending on the route of delivery. Mi...

Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage

This study is a randomized, double-blind, placebo controlled trial that will enroll 250 women (125 per study arm). The objective of the study is to determine the efficacy and tolerability...

Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage

The aim of the study is to evaluate the effect of oral tranexamic acid plus, sublingual misoprostol in the management of atonic postpartum hemorrhage (PPH) after vaginal delivery

Medical and Biotech [MESH] Definitions

Administration of a soluble dosage form by placement under the tongue.

Transient autoimmune thyroiditis occurring in the POSTPARTUM PERIOD. It is characterized by the presence of high titers of AUTOANTIBODIES against THYROID PEROXIDASE and THYROGLOBULIN. Clinical signs include the triphasic thyroid hormone pattern: beginning with THYROTOXICOSIS, followed with HYPOTHYROIDISM, then return to euthyroid state by 1 year postpartum.

The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.

A form of retention cyst of the floor of the mouth, usually due to obstruction of the ducts of the submaxillary or sublingual glands, presenting a slowly enlarging painless deep burrowing mucocele of one side of the mouth. It is also called sublingual cyst and sublingual ptyalocele.

Inflammation of the ENDOMETRIUM, usually caused by intrauterine infections. Endometritis is the most common cause of postpartum fever.

Quick Search


DeepDyve research library

Searches Linking to this Article